skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

29 Total results for product and free and sample content found

Generics Bulletin

Informa’s Global Generics & Biosimilars Awards Slated for Milan, Italy This Summer

05 Mar 2021

Informa’s Global Generics & Biosimilars Awards Slated for Milan, Italy This Summer

London – 5 March, 2021 – Planning is underway for the 2021 Global Generics & Biosimilars Awards. The awards, now in their eighth year, celebrate successes across the generics, biosimilars, and value-added medicines industries. 

Topic Biosimilars Press Release

Datamonitor Healthcare

The evolving landscape of biosimilars

27 Nov 2020

The evolving landscape of biosimilars

It is important to understand how the biosimilar market has developed over the past five years. Take a look at some of the key events here.

Topic Biosimilars

Generics Bulletin

Pfizer Reports 80% Biosimilars Growth In Q3

By Akriti Seth 17 Nov 2020

pfizer biosimilars growth

Pfizer has reported 80% growth in its global biosimilars business for the third quarter of 2020, on the back of recent oncology launches. Though the company’s sterile injectables saw a slight drop in business, Pfizer’s biopharma business saw 4% growth.

Topic Coronavirus Biosimilars Deals

Generics Bulletin

Top 50 Generics and Biosimilars Companies

07 Sep 2020

Top 50 Companies Article Pack

The Annual Top 50 Generics & Biosimilars Companies League Table is here, and Generics Bulletin is sharing its content with you! Connect to league tables and commentary summarizing key developments for the Top 10 companies in generics and biosimilars, part of Generics Bulletin’s annual Top 50 ranking.

Topic Biosimilars

Generics Bulletin

Biosimilars Conference Coverage

30 Apr 2020

Biosimilars Conference Coverage

Industry analysts from Generics Bulletin are bringing you free insights from their comprehensive biosimilars coverage. Obtain critical industry information covering new biosimilars launches, company strategies, and new biosimilars product development.

Topic Biosimilars

Pink Sheet

Mylan/Biocon's Insulin Glargine Would Get A Respite Under US Budget Legislation

By Cathy Kelly 18 Dec 2019

MylanBiocons_Insulin_Glargine_Would_Get

Bill addresses ‘dead zone’ for pending applications for protein products transitioning to biologic status; generic and brand industries each win in different legislative provisions: inclusion of the CREATES Act, and a revised definition for ‘biologics’ that includes chemically synthesized polypeptides.

Topic Biosimilars Legislation

Generics Bulletin

Aurobindo Is Company Of The Year At GGB Awards

By David Wallace 13 Nov 2019

Article

Aurobindo has taken home the awards for Company of the Year and Acquisition of the Year at the Global Generics & Biosimilars Awards 2019, held in Frankfurt, Germany. Accord also received two awards, among a host of other recognized companies.

Topic Biosimilars

Generics Bulletin

Teva Debuts US Rituximab At A 10% Discount

By David Wallace 08 Nov 2019

Article

Teva and Celltrion have launched the first biosimilar rituximab in the US, introducing Truxima at a 10% discount to Roche’s Rituxan.

Topic Biosimilars Strategy

Custom Intelligence Biosimilars Whitepaper

By Duncan Emerton 04 Nov 2019

Custom Intelligence Biosimilars Whitepaper

If you’re looking at the opportunities to increase revenue and mitigate current and future threats by formulating the strongest biosimilars strategy, Informa’s Biosimilars Insights and Analysis Service is the tool you need.

Topic Biosimilars

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: